Is Zentalis Pharmaceuticals, Inc. on track for accelerated approval in ovarian cancer
Can azenosertib secure accelerated approval? Explore how Zentalis Pharmaceuticals, Inc.’s trials could reshape ovarian cancer treatment.
Pharma & Biotech